Corporate Voting Rights Updates
Major UK Firms Issue Latest Updates on Voting Rights and Share Capital
Anonymous
Key Points
1
Fuller’s issued capital comprised 34,082,515 A ordinary shares, 89,052,625 B ordinary shares and 12,965,837 C ordinary shares, with each share carrying one vote.
2
Fuller’s treasury holdings consisted of 3,152,588 A ordinary shares and 4,327,915 B ordinary shares.
3
Burberry’s 5,608 shares were issued on various dates from 9 September to 30 September 2026; they had already been admitted to trading under an existing block admission from August 2020.
Three UK firms disclosed voting rights and securities updates as of late September 2026. Fuller, Smith & Turner reported 30,929,927 total voting rights after accounting for treasury shares Yahoo Finance, while Burberry issued 5,608 shares under its Sharesave Plan and holds 363,855,448 voting rights Sharecast. AstraZeneca filed a regulatory notice for further securities admission but provided no details on the securities involved TradingView.
Fuller's Share Structure and Treasury Holdings
Fuller, Smith & Turner's issued capital breaks down into three classes of ordinary shares. The company holds 34,082,515 A ordinary shares, 89,052,625 B ordinary shares, and 12,965,837 C ordinary shares Wallstreet Online. Each share carries one vote.
The company removed 3,152,588 A ordinary shares and 4,327,915 B ordinary shares from treasury holdings when calculating voting rights Wallstreet Online. This exclusion reduced the total voting count to 30,929,927 as of September 30, 2026.
Burberry's Sharesave Issuance and Voting Rights
Burberry issued 5,608 shares across multiple dates between September 9 and September 30, 2026 Sharecast. These shares were admitted to trading under an existing block admission that dates back to August 2020.
The fashion retailer reported 363,855,448 total voting rights with no shares held in treasury Sharecast. The Sharesave Plan allows eligible employees to purchase shares at a discounted price over a set period.
AstraZeneca's Securities Admission Notice
AstraZeneca filed a regulatory notification with the London Stock Exchange concerning the admission of further securities to trading TradingView. The pharmaceutical giant submitted the notice on October 2, 2026, through the exchange's RNS news service.
The filing contained no specific details about the securities being admitted or their quantity TradingView. Such notices are routine regulatory filings that allow companies to expand their tradable securities on the LSE.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
15
Articles
22
Reach
37
A
AnonymousAuthor
